Ads
related to: Renal Cell Carcinoma- How This Treatment Works
Learn More About How This
FDA-Approved Treatment Works.
- FAQs
Find FAQs For This Treatment
Option On The Official Patient Site
- Patient Resources
Find Patient Resources
On The Official Site.
- Dosing Information
Get Dosing And Treatment
Schedule Information.
- How This Treatment Works
Search results
Merck (MRK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 15 minutes agoOutside the U.S., KEYTRUDA growth was driven by continued uptake in earlier-stage cancers, including high-risk, early stage, triple-negative breast...
Drug targeting clear cell renal cell carcinoma shows promising approach
Newswise· 3 days agoApril 23, 2024 – In a groundbreaking phase one clinical trial led by UT Southwestern Medical Center,...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 4 hours agoKeytruda, the biggest product in Merck’s portfolio, generated sales of $6.95 billion in the quarter,...
Moriah Elyse Kerns - Valencia County News-Bulletin
Valencia County News-Bulletin· 8 hours agoMoriah Elyse Kerns, age 27, a resident of Los Lunas, passed away on April 20, 2024, as a result of renal cell carcinoma. Moriah was pursuing ...
Merck highlights progress on HIV, hypertension, cervical cancer drugs
WFMZ Eastern Pennsylvania and Western New Jersey· 3 hours agoMerck got off to an excellent start in the first quarter of 2024. Wall Street met the news with...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 1 day agoPatients will receive Keytruda or Keytruda plus the vaccine after bladder or kidney removal. Bladder...
Cancer drug trial provides lessons for future
Medical Xpress· 3 hours agoA cancer drug was found to be ineffective in preventing recurrence of kidney cancer in patients who recently underwent tumor removal surgery, according to a clinical trial published in the Journal ...
Merck beats earnings forecasts as cancer drug sales boom
Crain's New York Business· 3 hours agoThe guidance comes as Merck’s first-quarter earnings topped $15.8 billion, a 9% increase from the...
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
WKBN 27 Youngstown· 18 hours agoFirst-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients with advanced colorectal cancer: Safety and efficacy results from a phase I study. First-in-class PD-1/IL-2 bispecific ...
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 3 days agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine,...
Ads
related to: Renal Cell Carcinoma
